EC Healthcare has issued a profit warning for the six months ended 30 September 2025. Based on preliminary unaudited consolidated management accounts, the company expects its revenue for the reporting period to decrease by no more than 10% compared to approximately HK$2,062.9 million for the same period in 2024. The decline in financial results is attributed to weak local consumption sentiment, increased spending by Hong Kong residents on medical and wellness services in Mainland China, higher outbound travel, the absence of revenue from previously disposed medical assets, a less favourable service mix, and reduced operating leverage from lower revenue. The company noted that its overall balance sheet remains strong, with a solid position in cash, time deposits, and current financial assets. The official consolidated results for the period are expected to be released on 28 November 2025. Shareholders and potential investors are advised to exercise caution when dealing in the company's shares.